Clinical Trials Directory

Trials / Unknown

UnknownNCT00327483

Web Based Renal Transplant Patient Medication Education

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
250 (planned)
Sponsor
Agency for Healthcare Research and Quality (AHRQ) · Federal
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.

Detailed description

Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (\<6 months) and established (\> 6 months), kidney transplant recipients is proposed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInternet based education software

Timeline

Start date
2005-07-01
Completion
2006-04-01
First posted
2006-05-18
Last updated
2006-05-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00327483. Inclusion in this directory is not an endorsement.